Home

spojka dokumentární Neštěstí heterogeneous palladium catalysts prodrug activation mikroskop chytrý abstraktní

Inâ•'Cell Dual Drug Synthesis by Cancerâ•'Targeting Palladium Catalysts
Inâ•'Cell Dual Drug Synthesis by Cancerâ•'Targeting Palladium Catalysts

Development and bioorthogonal activation of palladium-labile prodrugs of  gemcitabine. - Abstract - Europe PMC
Development and bioorthogonal activation of palladium-labile prodrugs of gemcitabine. - Abstract - Europe PMC

Extracellular palladium-catalysed dealkylation of  5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach  | Nature Communications
Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach | Nature Communications

Bright insights into palladium-triggered local chemotherapy - Chemical  Science (RSC Publishing)
Bright insights into palladium-triggered local chemotherapy - Chemical Science (RSC Publishing)

Extracellular palladium-catalysed dealkylation of  5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach  | Nature Communications
Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach | Nature Communications

Cancer-derived exosomes loaded with ultrathin palladium nanosheets for  targeted bioorthogonal catalysis | Request PDF
Cancer-derived exosomes loaded with ultrathin palladium nanosheets for targeted bioorthogonal catalysis | Request PDF

Design and Engineering of Metal Catalysts for Bio-orthogonal Catalysis in  Living Systems - ACS Appl. Bio Mater. - X-MOL
Design and Engineering of Metal Catalysts for Bio-orthogonal Catalysis in Living Systems - ACS Appl. Bio Mater. - X-MOL

Theranostics Palladium-based nanomaterials for cancer imaging and therapy
Theranostics Palladium-based nanomaterials for cancer imaging and therapy

A) Palladium-mediated dealkylation of compounds 3a-e, 6, and 7 and... |  Download Scientific Diagram
A) Palladium-mediated dealkylation of compounds 3a-e, 6, and 7 and... | Download Scientific Diagram

Intracellular delivery of a catalytic organometallic complex - Chemical  Communications (RSC Publishing) DOI:10.1039/C7CC02988H
Intracellular delivery of a catalytic organometallic complex - Chemical Communications (RSC Publishing) DOI:10.1039/C7CC02988H

Designed heterogeneous palladium catalysts for reversible light-controlled  bioorthogonal catalysis in living cells | Nature Communications
Designed heterogeneous palladium catalysts for reversible light-controlled bioorthogonal catalysis in living cells | Nature Communications

Edinburgh Research Explorer
Edinburgh Research Explorer

Bioorthogonal Uncaging of the Active Metabolite of Irinotecan by Palladium‐Functionalized  Microdevices - Adam - 2018 - Chemistry – A European Journal - Wiley  Online Library
Bioorthogonal Uncaging of the Active Metabolite of Irinotecan by Palladium‐Functionalized Microdevices - Adam - 2018 - Chemistry – A European Journal - Wiley Online Library

Design of highly active heterogeneous palladium catalysts for the activation  of aryl chlorides in Heck reactions - ScienceDirect
Design of highly active heterogeneous palladium catalysts for the activation of aryl chlorides in Heck reactions - ScienceDirect

Nanomaterials | Free Full-Text | An Up-To-Date Review on Biomedical  Applications of Palladium Nanoparticles | HTML
Nanomaterials | Free Full-Text | An Up-To-Date Review on Biomedical Applications of Palladium Nanoparticles | HTML

PDF) Nano-palladium is a cellular catalyst for in vivo chemistry
PDF) Nano-palladium is a cellular catalyst for in vivo chemistry

Designed heterogeneous palladium catalysts for reversible light-controlled  bioorthogonal catalysis in living cells | Nature Communications
Designed heterogeneous palladium catalysts for reversible light-controlled bioorthogonal catalysis in living cells | Nature Communications

Discovery Chemistry Congress 2015 Playlist | LabTube
Discovery Chemistry Congress 2015 Playlist | LabTube

Frontiers | Bystander Effects of Hypoxia-Activated Prodrugs: Agent-Based  Modeling Using Three Dimensional Cell Cultures | Pharmacology
Frontiers | Bystander Effects of Hypoxia-Activated Prodrugs: Agent-Based Modeling Using Three Dimensional Cell Cultures | Pharmacology

Bioorthogonally activated prodrug strategy and toxigenic mode of... |  Download Scientific Diagram
Bioorthogonally activated prodrug strategy and toxigenic mode of... | Download Scientific Diagram

A) Study of prodrugs' bioorthogonality. Semi Log dose response curves... |  Download Scientific Diagram
A) Study of prodrugs' bioorthogonality. Semi Log dose response curves... | Download Scientific Diagram

Synthesis of compounds 3a-e (upper panel) and compounds 6, 7 (lower panel).  | Download Scientific Diagram
Synthesis of compounds 3a-e (upper panel) and compounds 6, 7 (lower panel). | Download Scientific Diagram

Efficient Palladium-Triggered Release of Vorinostat from a Bioorthogonal  Precursor – topic of research paper in Chemical sciences. Download  scholarly article PDF and read for free on CyberLeninka open science hub.
Efficient Palladium-Triggered Release of Vorinostat from a Bioorthogonal Precursor – topic of research paper in Chemical sciences. Download scholarly article PDF and read for free on CyberLeninka open science hub.

Bioorthogonal Uncaging of the Active Metabolite of Irinotecan by Palladium‐Functionalized  Microdevices - Adam - 2018 - Chemistry – A European Journal - Wiley  Online Library
Bioorthogonal Uncaging of the Active Metabolite of Irinotecan by Palladium‐Functionalized Microdevices - Adam - 2018 - Chemistry – A European Journal - Wiley Online Library

Figure 2 from Nano-palladium is a cellular catalyst for in vivo chemistry |  Semantic Scholar
Figure 2 from Nano-palladium is a cellular catalyst for in vivo chemistry | Semantic Scholar

Edinburgh Research Explorer
Edinburgh Research Explorer

Nano-palladium is a cellular catalyst for in vivo chemistry | Nature  Communications
Nano-palladium is a cellular catalyst for in vivo chemistry | Nature Communications

Periodic Reporting for period 1 - ChemoBOOM (Development of Palladium-Labile  Prodrugs for Bioorthogonally-Activated Chemotherapy) | Report Summary |  ChemoBOOM | H2020 | CORDIS | European Commission
Periodic Reporting for period 1 - ChemoBOOM (Development of Palladium-Labile Prodrugs for Bioorthogonally-Activated Chemotherapy) | Report Summary | ChemoBOOM | H2020 | CORDIS | European Commission